Food Importer Tomer Returns to Trading After Stock Manipulation Scandal
Translated & summarized from TheMarker by baba
Food importer Tomer resumed trading on the Tel Aviv Stock Exchange today after a two-month suspension. Controlling shareholder Doron Kimelov was removed as Chairman due to artificially inflating inventory and profits, though he remains CEO. Riviv Brokheimer was appointed as the new Chairman. The company's stock dropped 15% at the market open.
The story in 5 lines · by baba
- Food importer Tomer resumed trading on the Tel Aviv Stock Exchange today.
- Controlling shareholder Doron Kimelov was removed as Chairman due to stock manipulation.
- Riviv Brokheimer has been appointed as the new Chairman of Tomer.
- Doron Kimelov will continue to serve as the company's CEO.
- Tomer's stock fell 15% at the opening of trading.
The food importing company Tomer is resuming trading on the Tel Aviv Stock Exchange today, after a suspension of nearly two months. The company announced that its controlling shareholder, Doron Kimelov, has been removed from his position as Chairman. Riviv Brokheimer has been appointed as the new Chairman. Kimelov will continue to serve as the company's CEO. Brokheimer currently holds the position of Deputy Chairman at Extra Retail, the private retail arm of the Alon Blue Square Group, which is controlled by Moty Ben-Moshe. Previously, Brokheimer served as CEO of Wissotzky Tea and Golf. The trading suspension followed the re-publication of financial reports and findings from an investigation that determined Kimelov had artificially inflated the company's inventory and profits. Kimelov's salary will be reduced, and he will forfeit some bonuses as part of the fallout from the investigation. Tomer's stock fell 15% at the opening of trading.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 1Other 3
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
